Specialties

At the the AACE 2017 convention in Austin, Texas, Dr. Matthew Weir and Diabetes in Control Publisher Steve Freed discuss the impact of SGLT2 drugs in helpful as well as possibly harmful ways. They also look at the need for safety studies for kidney disease. Dr. Matthew Weir, MD is …

At the AACE 2017 convention in Austin, Texas, Dr. Matthew Weir talks with Diabetes in Control Publisher Steve Freed about how he detects kidney disease in an effort to catch and treat the condition in its early stages. Dr. Matthew Weir, MD is a professor of medicine and director of …

Glucose peaks tied to greater cognitive decline for those with diabetes and A1c ≥7.0 percent.

Results showed that the intervention will be cost effective.

Results from the ongoing first large real-world evidence study of its kind published in the American Heart Association.

Study focused on type 2 diabetes patients who initiate metformin.

Study from Women's Health Initiative sought to determine whether low fasting glucose levels are associated with cardiovascular events and/or mortality.

Cognitive decline can accelerate, making patients especially vulnerable to mental impairment and dementia as they age.

Youths who received any breastfeeding for at least 12 months or full breastfeeding for at least six months had lower odds of developing type 1 diabetes.

A low-risk intervention with potentially high rewards.